Cart
sales@molnova.com
HAEGT
CAS No. 852155-81-8
HAEGT( —— )
Catalog No. M30080 CAS No. 852155-81-8
HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 425 | Get Quote |
|
| 10MG | 608 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHAEGT
-
NoteResearch use only, not for human use.
-
Brief DescriptionHAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.
-
DescriptionHAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.
-
In VitroHAEGT (0-500 μM) is a competitive substrate for probing prime substrate binding sites of human dipeptidyl peptidase-IV (DPP-IV).HAEGT can be catalyzed cleavage by DPP-IV with a km value of 38 μM, Kcat value of 3.1 S-1.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number852155-81-8
-
Formula Weight513.5
-
Molecular FormulaC20H31N7O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:His-Ala-Glu-Gly-Thr
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GLP-1R modulator C5
GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes.
-
Tirzepatide
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
-
Lotiglipron
Lotiglipron (PF-07081532) is an orally active, potent GLP-1R agonist that reduces blood glucose and body weight, potentially aiding in the study of type 2 diabetes mellitus (T2DM) and obesity.
